Premium Serums And Vaccines Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 23-06-2024
- Paid Up Capital ₹ 2.00 Cr
as on 23-06-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 56.57 Cr
as on 23-06-2024
- Revenue 4.60%
(FY 2022)
- Profit 168.57%
(FY 2022)
- Ebitda 52.59%
(FY 2022)
- Net Worth 75.22%
(FY 2022)
- Total Assets -3.89%
(FY 2022)
About Premium Serums And Vaccines
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹56.57 Cr.
Shyam Dhawan and Girish Kolwankar serve as directors at the Company.
- CIN/LLPIN
U24110MH2009PTC189968
- Company No.
189968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Premium Serums And Vaccines?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Dhawan  | Director | 29-Jan-2009 | Current |
| Girish Kolwankar | Director | 29-Jan-2009 | Current |
Financial Performance and Corporate Structure Insights of Premium Serums And Vaccines.
Premium Serums And Vaccines Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.6% increase. The company also saw a substantial improvement in profitability, with a 168.57% increase in profit. The company's net worth Soared by an impressive increase of 75.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Premium Serums And Vaccines?
In 2022, Premium Serums And Vaccines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Premium Chick Feeds Private LimitedActive 33 years 6 monthsShyam Dhawan and Girish Kolwankar are mutual person
Premium Agro Industries P.Ltd.Active 31 years 4 monthsShyam Dhawan and Girish Kolwankar are mutual person
- Alpha Feeds Private LimitedActive 2 years 5 months
Shyam Dhawan and Girish Kolwankar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 May 2023 | ₹1.00 M | Open |
Others Creation Date: 16 Jun 2020 | ₹3.57 Cr | Open |
Others Creation Date: 16 Feb 2018 | ₹6.50 Cr | Open |
How Many Employees Work at Premium Serums And Vaccines?
Premium Serums And Vaccines has a workforce of 82 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Premium Serums And Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premium Serums And Vaccines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
